Advertisement

Loading...

Aleafia Health Inc.

AH.TOTSX
Healthcare
Drug Manufacturers - Specialty & Generic
$0.02
$0.005(33.33%)
Canadian Market opens in 14h 55m

Aleafia Health Inc. Fundamental Analysis

Aleafia Health Inc. (AH.TO) shows weak financial fundamentals with a PE ratio of -0.18, profit margin of -98.77%, and ROE of -58.25%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.00

Areas of Concern

ROE-58.25%
Operating Margin-40.93%
We analyze AH.TO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -69.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-69.2/100

We analyze AH.TO's fundamental strength across five key dimensions:

Efficiency Score

Weak

AH.TO struggles to generate sufficient returns from assets.

ROA > 10%
-70.62%

Valuation Score

Excellent

AH.TO trades at attractive valuation levels.

PE < 25
-0.18
PEG Ratio < 2
-0.00

Growth Score

Weak

AH.TO faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

AH.TO maintains a strong and stable balance sheet.

Debt/Equity < 1
-5.20
Current Ratio > 1
1.01

Profitability Score

Weak

AH.TO struggles to sustain strong margins.

ROE > 15%
-5824.59%
Net Margin ≥ 15%
-98.77%
Positive Free Cash Flow
No

Key Financial Metrics

Is AH.TO Expensive or Cheap?

P/E Ratio

AH.TO trades at -0.18 times earnings. This suggests potential undervaluation.

-0.18

PEG Ratio

When adjusting for growth, AH.TO's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Aleafia Health Inc. at -0.87 times its book value. This may indicate undervaluation.

-0.87

EV/EBITDA

Enterprise value stands at 3.45 times EBITDA. This is generally considered low.

3.45

How Well Does AH.TO Make Money?

Net Profit Margin

For every $100 in sales, Aleafia Health Inc. keeps $-98.77 as profit after all expenses.

-98.77%

Operating Margin

Core operations generate -40.93 in profit for every $100 in revenue, before interest and taxes.

-40.93%

ROE

Management delivers $-58.25 in profit for every $100 of shareholder equity.

-58.25%

ROA

Aleafia Health Inc. generates $-70.62 in profit for every $100 in assets, demonstrating efficient asset deployment.

-70.62%

Following the Money - Real Cash Generation

Operating Cash Flow

Aleafia Health Inc. generates limited operating cash flow of $-3.63M, signaling weaker underlying cash strength.

$-3.63M

Free Cash Flow

Aleafia Health Inc. generates weak or negative free cash flow of $-5.36M, restricting financial flexibility.

$-5.36M

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

AH.TO converts -63.63% of its market value into free cash.

-63.63%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.18

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.87

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.19

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-5.20

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.006

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.58

vs 25 benchmark

ROA

Return on assets percentage

-0.71

vs 25 benchmark

ROCE

Return on capital employed

-0.72

vs 25 benchmark

How AH.TO Stacks Against Its Sector Peers

MetricAH.TO ValueSector AveragePerformance
P/E Ratio-0.1828.31 Better (Cheaper)
ROE-58.25%699.00% Weak
Net Margin-98.77%-131318.00% (disorted) Weak
Debt/Equity-5.200.34 Strong (Low Leverage)
Current Ratio1.012775.16 Neutral
ROA-70.62%-14513.00% (disorted) Weak

AH.TO outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Aleafia Health Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ